Research is being conducted on colorectal cancer, including trials for BRAF-mutant and KRAS-mutant cases. Some studies are examining potential therapies, such as KRAS-targeted therapies and tumor vaccines, although it is unclear if these are specifically for colorectal cancer or other types like pancreatic cancer. The focus of these efforts includes understanding the molecular features of the disease and addressing treatment resistance in metastatic cases.